1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Lead: new trials by email Literature Review of Lead trials Research Report on Lead
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Lerociclib in Participants With Advanced Breast Cancer Lerociclib + Letrozole or Fulvestrant - Advanced Breast Cancer | Phase 2 | Terminated | EQRx, Inc. | 100 | 2021-12-21 | 2026-05-14 |
EQRx, Inc. (1)
Belgium (1) · Georgia (1) · Italy (1) · Mexico (1) · Moldova (1) · United States (1)